On Monday, the flavour and fragrance manufacturer Symrise announced that it acquired a minority stake in Danish aroma company EvodiaBio. Shares of the German company Symrise were losing around 6% in the morning trading in Germany after it warned about its fiscal 2022 results over the weekend due to an impairment loss. The loss amounted to €126 million ($136.987 million) and related to its interest in the pharmaceutical company Swedencare, which Symrise recognized in the fourth quarter. The company further reaffirmed its long-term growth and profitability goals later, however. The minority shar…